BlackRock Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $39K | Buy |
8,163
+323
| +4% | +$1.54K | ﹤0.01% | 3234 |
|
|
2016
Q3 | $52K | Buy |
7,840
+2,349
| +43% | +$15.6K | ﹤0.01% | 3167 |
|
|
2016
Q2 | $30K | Buy |
5,491
+49
| +0.9% | +$268 | ﹤0.01% | 3295 |
|
|
2016
Q1 | $116K | Buy |
5,442
+499
| +10% | +$10.6K | ﹤0.01% | 2799 |
|
|
2015
Q4 | $156K | Sell |
4,943
-248
| -5% | -$7.83K | ﹤0.01% | 2666 |
|
|
2015
Q3 | $179K | Buy |
5,191
+214
| +4% | +$7.38K | ﹤0.01% | 2749 |
|
|
2015
Q2 | $157K | Buy |
4,977
+841
| +20% | +$26.5K | ﹤0.01% | 2899 |
|
|
2015
Q1 | $121K | Buy |
4,136
+1,434
| +53% | +$42K | ﹤0.01% | 2921 |
|
|
2014
Q4 | $50K | Sell |
2,702
-273
| -9% | -$5.05K | ﹤0.01% | 3235 |
|
|
2014
Q3 | $52K | Hold |
2,975
| – | – | ﹤0.01% | 3218 |
|
|
2014
Q2 | $60K | Buy |
+2,975
| New | +$60K | ﹤0.01% | 3190 |
|